Upgrade

Burning Rock Biotech Limited

BNR

Last
$15.49
Day
+1.9%
1y
+70.8%
5y
-21.4%
52w
-63.6%
SPY YTD
+13.3%
XLV
+8.1%
Earnings
2026-11-1939d
EMA 21
15.08
EMA 50
13.33
EMA 200
13.71
20d high
-22.4%
5y high
-63.6%
5y range
36th
Website · 667 employees · China

Positions held

Your positions

BNR isn't in your positions.

Add it to see shares, cost, and P&L here.

Score
35
Hold
swing
Signal
Strong Buy
Target
$18.30
Stop
$12.61
Stop distance
18.6%
Target vs last
+18.1%

Fundamentals

Market cap$160.30MEnterprise value-$206.63MTrailing P/E—Forward P/E-26.21
PEG—Price / book2.23Beta1.29Dividend yield0.00%
Revenue growth-9.3%Earnings growth—Gross margin74.6%Operating margin-13.4%
Profit margin-13.6%ROE-12.8%ROA-5.2%Debt / equity0.09
Current ratio3.05Free cash flow$12.98MAnalyst recommendationnoneMean target—
52w high$41.7252w low$6.79

Quarterly

2026-Q12025-Q42025-Q32025-Q22025-Q1
Revenue$108M$126M$132M$149M$133M
Op margin-17.5%-9.5%-12.3%-7.7%-11.4%
Net income-$17.5M-$15.4M-$16.8M-$9.7M-$13.5M
Gross margin72.3%78.0%75.1%72.8%73.2%
Gross profit$78.0M$98.6M$98.8M$108M$97.4M
Operating income-$18.8M-$12.0M-$16.1M-$11.5M-$15.2M
  • Revenue -15% vs prior quarter ($108M vs $126M).
  • Gross margin 72.3% (was 78% prior quarter).
  • Operating margin compressed to -17.5%.

Yearly (6y)

20252024202320222021
Revenue$540M$516M$537M$563M—
Op margin-10.2%-62.5%-124.5%-174.1%—
Net income-$55.3M-$347M-$654M-$971M—
Gross margin74.7%70.3%67.6%67.5%—
Gross profit$403M$362M$363M$380M—
Operating income-$54.8M-$322M-$669M-$980M—
Headline scan

No flags

• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).

News

BNR · daily+3.2% over 14 sessions
Close EMA21 EMA50 EMA200
14.0915.5316.9818.4219.862026-092026-092026-092026-092026-102026-102026-10
Quarterly · revenue, net income, margins
Revenue Net income Gross margin Op margin
-$17M$24M$66M$107M$149M-17%30%78%2025-Q12025-Q22025-Q32025-Q42026-Q1